No, maintenance treatment should not be used outside clinical trials

David H. Vesole; David S. Siegel

No, maintenance treatment should not be used outside clinical trials

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Maintenance therapy in MM has been under investigation for decades. Before the introduction of novel therapies (PIs and IMiDs), maintenance therapy using corticosteroids, interferon, or chemotherapy was deemed too toxic, ineffective, or minimally effective.

Original language	English
Pages (from-to)	163-169
Number of pages	7
Journal	Clinical Advances in Hematology and Oncology
Volume	13
Issue number	3
State	Published - 2015

Cite this

@article{b9ce31dda76747ae99b4a2446b245edb,

title = "No, maintenance treatment should not be used outside clinical trials",

abstract = "Maintenance therapy in MM has been under investigation for decades. Before the introduction of novel therapies (PIs and IMiDs), maintenance therapy using corticosteroids, interferon, or chemotherapy was deemed too toxic, ineffective, or minimally effective.",

author = "Vesole, \{David H.\} and Siegel, \{David S.\}",

note = "Publisher Copyright: {\textcopyright} 2015 Clinical Advances in Hematology \& Oncology All right received.",

year = "2015",

language = "English",

volume = "13",

pages = "163--169",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "3",

}

TY - JOUR

T1 - No, maintenance treatment should not be used outside clinical trials

AU - Vesole, David H.

AU - Siegel, David S.

PY - 2015

Y1 - 2015

N2 - Maintenance therapy in MM has been under investigation for decades. Before the introduction of novel therapies (PIs and IMiDs), maintenance therapy using corticosteroids, interferon, or chemotherapy was deemed too toxic, ineffective, or minimally effective.

AB - Maintenance therapy in MM has been under investigation for decades. Before the introduction of novel therapies (PIs and IMiDs), maintenance therapy using corticosteroids, interferon, or chemotherapy was deemed too toxic, ineffective, or minimally effective.

UR - https://www.scopus.com/pages/publications/84975788859

M3 - Article

C2 - 26352424

AN - SCOPUS:84975788859

SN - 1543-0790

VL - 13

SP - 163

EP - 169

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 3

ER -

No, maintenance treatment should not be used outside clinical trials

Abstract

Other files and links

Fingerprint

Cite this